We describe a "protein knockout" technique that can be used to identify essential proteins in bacteria. This technique uses phage display to select peptides that bind specifically to purified target proteins. The peptides are expressed intracellularly and cause inhibition of growth when the protein is essential. In this study, peptides that each specifically bind to one of seven essential proteins were identified by phage display and then expressed as fusions to glutathione S-transferase in Escherichia coli. Expression of peptide fusions directed against E. coli DnaN, LpxA, RpoD, ProRS, SecA, GyrA, and Era each dramatically inhibited cell growth. Under the same conditions, a fusion with a randomized peptide sequence did not inhibit cell growth. In growthinhibited cells, inhibition could be relieved by concurrent overexpression of the relevant target protein but not by coexpression of an irrelevant protein, indicating that growth inhibition was due to a specific interaction of the expressed peptide with its target. The protein knockout technique can be used to assess the essentiality of genes of unknown function emerging from the sequencing of microbial genomes. This technique can also be used to validate proteins as drug targets, and their corresponding peptides as screening tools, for discovery of new antimicrobial agents.
Despite the success of antimicrobial agents, infectious disease is now the second leading cause of death worldwide (14) . This is in large part due to increased resistance of pathogens to a variety of antimicrobials and is an accelerating trend. It is evident that the dynamic and resilient nature of microbial life, coupled with the profligate use of antibiotics, has selected drug-resistant microbes across a wide spectrum of pathogenic organisms. There is a clear and urgent need for novel antibiotics to help combat this problem (8, 10, 30) .
Although most antibiotics in use today are directed against a small number of bacterial targets, there is no shortage of potential targets. Analyses of bacterial genomes have allowed estimates of the "minimal genome set" of genes essential for viability. A comparison of the genomes of Haemophilus influenzae and Mycoplasma genitalium identified 256 genes considered necessary and sufficient for cell viability, while a study of the frequency of indispensable genes in the Bacillus subtilis genome arrived at 250 to 450 essential genes (25, 32) . This range of genes should thus constitute the number of potential targets for antimicrobial drug discovery, a number far larger than the dozen or so sites of action for all currently existing antibiotics. Genome-sequencing efforts have increased the potential for development of new classes of antibiotics directed against novel targets (15, 39, 42) . Among the potential targets revealed by sequencing are those of unknown function, as well as those of known function that have never been used as drug targets. There is a pressing need for technologies that can validate or invalidate targets for drug discovery by showing whether they are essential for microbial survival.
Here we describe a "protein knockout" method for demonstrating the essentiality of bacterial proteins that requires no prior knowledge of protein function. Proteins are expressed, purified, and used in phage display to isolate peptides that bind specifically to them. The peptides are then expressed intracellularly as glutathione S-transferase (GST) fusions, and their effect on growth is monitored. If the protein is essential, cell growth should be inhibited.
The protein knockout strategy builds on several observations reported previously. We and others have shown that many peptides selected in phage display are directed to functional sites on target proteins (reviewed in reference 26). In an extension of our previous work in isolating a peptide inhibitor of prolyl-tRNA synthetase (ProRS) (24), Tao et al. showed that intracellular expression of this peptide fused to GST could slow bacterial growth and rescue mice from an otherwise lethal dose of virulent Escherichia coli. (46) . Specific inhibition of ProRS in the cell was demonstrated by a decrease in the intracellular pool of charged tRNA Pro . Walker et al. (47) expressed 20,000 peptides in E. coli and found that 21 of them were growth inhibitory; however, the targets of these peptides were unknown. This study showed the importance of using peptides fused to proteins or amino acid motifs to improve stability. Blum et al. (1) induced the expression of a library of peptides fused to thioredoxin and selected for cells possessing the ThyA Ϫ phenotype (trimethoprim resistance and a thymine requirement for growth). They discovered peptides that inhibited cell growth and found that the phenotype could be suppressed by overexpression of ThyA protein. Peptide expression has also been used to knock out protein function and dissect signal transduction pathways in eukaryotic cells (5, 7, 9, 13, 17, 18, 41) .
In this study, we showed that protein-specific peptides can first be selected in vitro and then used to assess the essentiality of a wide variety of proteins in bacteria. We demonstrated this method with proteins known to be essential for E. coli, including those involved in nearly every basic cellular process: DNA Phage display. Immulon 4 96-well plates (Thermo Labsystems, Franklin, Mass.) were coated with streptavidin (1 g/well) in 0.1 M sodium bicarbonate and blocked with 1% bovine serum albumin. Biotinylated protein (4 pmol/well) diluted into TBST (10 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.05% Tween 20) was allowed to bind to the plate for 1 h. The plates were washed with TBST, and phage from each of 20 recombinant M13 libraries (total complexity of 2 ϫ 10 10 ) were allowed to bind for 1 h. The plates were washed again, and the bound phage were eluted, amplified, and used for the next round of phage selection as described previously (44) . After three or four rounds of selection, phage pools were plated for single plaques and purified and the DNA sequence of individual isolates was determined. Peptides were synthesized to include the 12-to 15-amino-acid sequence displayed by the phage followed by a short linker and a biotin at the C terminus to allow labeling for analysis of peptide binding. Isolation and use of ProRS-specific phage has been described previously (24, 46) ; peptide Pro-3 in those publications is referred to as peptide 72 in this work.
Cloning vectors for intracellular expression of peptide fusion and protein. Two commercially available plasmids were altered for cloning purposes.
(i) Vector for peptide expression. Plasmid pPROTet.E332-lacZ was modified for cloning of peptide sequences as GST fusions by first introducing a cassette with SalI and NheI sites for peptide sequence cloning and then replacing the lacZ gene with the gst gene. Oligonucleotides ProtetSal/Nhe5 and ProtetSal/Nhe3 were annealed at 95°C for 2 min in 1ϫ SURE/CUT buffer B (Roche) and then allowed to cool to room temperature. The DNA was then cut with HindIII and KpnI and ligated into the pPROTet.E332-lacZ vector previously cut with HindIII and KpnI. Transformants were screened for the presence of the NheI site, and DNA sequences of the plasmids were confirmed. The gst gene was amplified by PCR from pGEX2T (Amersham BioSciences, Piscataway, N.J.) with primers tGST5 and tGST3. This set of primers also introduced a linker region between the multiple-cloning site and gst. The PCR product was cut with HindIII and PstI and ligated into the modified pPROTet.E332-lacZ vector cut with the same enzymes. Transformants were screened for presence of an introduced BamHI site, and plasmids were confirmed by sequence analysis. The resulting plasmid is pKBU-Tet/GST (Fig. 1A) .
(ii) Vector for target protein expression. Plasmid pProLar.A222 (Clontech) was modified by introducing a cassette with NdeI, BspHI, and SmaI cloning sites between the KpnI and PacI sites to create pKBU-Pro-Lar (Fig. 1B) .
Construction of plasmids for peptide expression. Each peptide expression plasmid (with the exception of the ProRS peptide-encoding plasmid) was made with a specific pair of 5Ј-phosphorylated oligonucleotides for insertion into the SalI and NheI cloning sites of pKBU-Tet/GST (Fig. 1A) . Each oligonucleotide was resuspended to 1 g/l in 10 mM Tris-HCl (pH 8.0)-1 mM EDTA (TE), and 9.5 l of the sense oligonucleotide and 9.5 l of the antisense oligonucleotide were mixed with 1 l of 5M NaCl in TE and placed in a heat block at 80°C. After 30 min, the block was removed from its heater and allowed to cool to 30°C. Each annealed cassette was diluted with TE to 200 l and then ligated into pKBUTet/GST; 2 l of each ligation mixture was transformed into 20 l of electrocompetent DH5␣Pro cells. Cells were plated onto medium containing chloramphenicol and grown overnight at 37°C. Several isolates from each ligation were picked and cultured, and insert-positive isolates were identified by PCR amplification with primers outside the insert region. Positive isolates were then sequenced with the oligonucleotide 5ЈProTet to confirm correct sequences of the peptide-coding inserts.
Construction of plasmids for protein expression. For intracellular expression experiments, target genes were removed from the pTYB2AT or pTYB4AT constructs used for protein production with the restriction sites used to clone them (or with flanking sites) and recloned into compatible sites in the vector pKBU-Pro-Lar (Fig. 1B) . The resulting constructs were transformed into JS5 cells, sequences were confirmed, and the plasmids were repurified and transformed into DH5␣Pro cells.
Induction of peptide fusions. Overnight cultures of sequence-confirmed constructs were diluted 1:100 (10 l into 1 ml) into a 96-well block with fresh selective medium and the addition of the inducer anhydrotetracycline (BD Biosciences/Clontech) to 100 ng/ml. These cultures were grown at 22°C with shaking, and optical densities (absorbance at 600 nm) were read in a SpectraMax 190 spectrophotometric plate reader (Molecular Devices, Sunnyvale, Calif.) at 12, 24, 36, and 48 h.
Coinduction of peptide fusions and target proteins. Cells bearing pKBU-Tetpeptide-GST constructs were made electrocompetent and were transformed with the pKBU-Pro-Lar-target constructs, plated onto 2ϫ YT plus kanamycin, and grown overnight at 37°C. Isolates were picked and grown in medium with chloramphenicol, spectinomycin, and kanamycin, and the presence of both constructs in the cells was confirmed by sequencing of the DNA with individual sets of plasmid-specific primers. Overnight cultures of cells bearing these plasmids were diluted 1:100 (10 l into 1 ml) into a 96-well block, with fresh selective medium containing the inducer of peptide expression, anhydrotetracyline (100 ng/ml), as well as the inducers of protein expression, L-(ϩ)-arabinose (0.2 %) and isopropyl-1-thio-␤-D-galactopyranoside (1 mM). Induced cultures were grown at 22°C, and optical densities were read after 48 h.
Cultures were also diluted 1:1,000 at 3 h after induction; plated onto 2ϫ YT solid medium containing chloramphenicol, spectinomycin, kanamycin, and inducers; and grown overnight at 37°C.
Western blotting. Equal volumes of overnight cultures of cells carrying pKBUTet-peptide-GST constructs were diluted into fresh selective medium containing inducer and grown at 37°C. At 0, 1, 2, 3, and 4 h, optical densities were measured and samples were taken. Cell samples were resuspended at a concentration of 1 absorbance unit at 600 nm per ml in SDS sample buffer (3% sodium dodecyl sulfate, 1 mM dithiothreitol, 10 % glycerol, 63 mM Tris-HCl [pH 6.8]), boiled for 2 min, and applied to 4 to 20% gradient polyacrylamide gels. The resolved proteins were electroblotted to polyvinylidene difluoride membranes and probed with anti-GST antibody covalently linked to alkaline phosphatase (Santa Cruz Biotechnology, Santa Cruz, Calif.). The blots were developed with WesternBlue substrate (Promega Corp., Madison, Wis.).
RESULTS
Isolation of peptides that bind specifically to essential E. coli proteins. The genes encoding DnaN, LpxA, RpoD, ProRS, SecA, GyrA, and Era are all essential in E. coli (2, 16, 29, 33, 35, 36, 40) . These genes were amplified by PCR from E. coli strain K-12 genomic DNA and cloned into expression vectors, their DNA sequences were confirmed, and the proteins were expressed and purified. Each biotinylated target protein was immobilized in individual wells of a streptavidin-coated plastic 96-well plate. Recombinant M13 phage from libraries with a total expected diversity of 2 ϫ 10 10 peptides were added to the plate to isolate binding phage. The selections carried out on all of the bacterial proteins yielded phage particles that bound specifically to the protein of interest and not to several irrelevant control proteins. Replicative intermediate DNA from these phage was sequenced to determine the amino acid sequences of the peptides displayed by the phage. Correlations were then drawn between amino acid sequences and strong binding to target (as assessed by relative phage affinity experiments [data not shown]), and representative peptides were chosen for synthesis. These synthetic peptides were characterized for relative binding and cross-competition (data not shown) to confirm binding and specificity. Peptides identified as being strong, specific binders were expressed intracellularly as GST fusions. Sequences of the peptides described in this report are shown in Table 1 .
Intracellular expression of peptide-GST fusions inhibits bacterial growth. Oligonucleotide cassettes were designed encoding the amino acid sequences of the protein-specific peptides isolated from phage display. A random control peptide was also designed with the same general amino acid composition of the growth-inhibitory peptides but different in primary sequence. Oligonucleotide cassettes were cloned into the expression vector pKBU-Tet/GST. Cells containing each construct were grown overnight at 37°C and then diluted 1:100 in fresh liquid media with or without the inducer anhydrotetracycline. These cultures were grown at 22°C, and the optical densities were tracked for 48 hours. Expression of a targetspecific peptide-GST fusion should inhibit cell growth (Fig. 2) . The expression of protein-specific peptide-GST fusions re- Fig. 3 . Western blotting of cells very soon after the induction of peptide expression using anti-GST antibodies showed that all fusions were expressed and that there was no correlation between growth inhibition and level of peptide expression (data not shown).
Expression of specific target protein rescues peptide-dependent growth inhibition. DNAs encoding the target proteins
LpxA and DnaN were subcloned into the expression vector pKBU/ProLar. Each new construct was transformed into cells containing either of the peptide-GST fusion constructs 920-GST or 1337-GST. Plasmid DNAs isolated from the transformants were sequenced, which confirmed the presence of both constructs (a peptide-GST fusion plasmid and a target plasmid) in each cell strain generated.
The peptide-GST fusion and the target protein were induced, either individually or simultaneously, and growth in liquid culture at 22°C was tracked for 48 h. Induction of LpxA alone had little effect on cell growth, and induction of DnaN alone had a slight inhibitory effect on cell growth. Overexpression of peptide fusions 920-GST and 1337-GST each resulted in significant growth inhibition. However, in cells expressing both a target protein and a peptide fusion, peptide-dependent growth inhibition could be fully or partially relieved, but only in a target-specific manner (Fig. 4) . These experiments were repeated several times with similar results. The same effects were seen with plated cultures ( 
DISCUSSION
We have demonstrated a protein knockout method by isolating peptides from phage display libraries that are specifically directed to essential bacterial proteins and by showing that intracellular expression of these peptides inhibits bacterial growth. In contrast, intracellular expression of peptides with the same amino acid composition but a scrambled sequence did not cause inhibition of growth. There was no correlation between growth inhibition and level of expression for all tested peptide-GST fusions. Therefore, the growth-inhibitory effects seen are due neither to mere protein overexpression nor to the amino acid composition of the fusions but, instead, require the specific amino acid sequence of the peptides identified via phage display. Furthermore, overexpression of target protein relieved inhibition caused by the corresponding peptide but not a different peptide for three of four proteins tested (DnaN, LpxA, and SecA). These findings support the hypothesis that intracellular expression of peptides directed to essential bacterial targets can interfere with cell growth. That this approach is successful with proteins known to be essential would predict that it will successfully identify essential proteins of unknown function encoded in microbial genomes.
It is not surprising that peptides selected to bind a specific protein would inhibit the function of that protein intracellularly. The phage display process selects peptides that bind active or functional sites rather than random sites on protein (21, 26) . Although this phenomenon is not completely understood, it is known that active sites possess physicochemical properties such as deep, flexible clefts that have evolved to bind ligands (28, 48) . In addition, peptide binding to these clefts is energetically favorable (11) . Accordingly, the activity of many enzymes can be inhibited by peptides in vitro, and this inhibition is quite specific. Enzymes inhibited in this way include prolyl-and tyrosyl-tRNA synthetases (24) However, it is difficult to draw conclusions if intracellular peptide expression does not lead to growth inhibition. We obtained this result with peptides isolated against the proteins dihydrofolate reductase (DHFR) and deoxyxylulose reductoisomerase (Dxr). Mutants defective in folA (encoding DHFR) are slow growing on rich media (22) , and mutants defective in yaeM (encoding Dxr) are not viable on rich media unless specifically supplemented with methylerythritol (45) . In both cases, the peptides we isolated by phage display were competed from the protein by antimicrobial drugs specific for that protein; additionally, one of the Dxr-specific peptides inhibited the biochemical activity of Dxr (reference 20 and data not shown). When growth inhibition by intracellular expression of such peptides is not seen, there are a number of possible explanations. These include nonessentiality of the protein, binding of the peptide to a site not relevant to the essential function of the protein, protection of the protein from peptide inhibition by substrate or by assembly into multienzyme complexes, and insufficient expression of the peptide. Furthermore, even if intracellular peptide-protein complexes are efficiently formed, a low level of residual activity from unbound protein may suffice for growth. Any of these factors could also cause incomplete growth inhibition, as seen in the present study, for example, with the SecA peptide. If sufficient numbers of peptides were tested, this ambiguity might be resolved for a given protein. This technique is thus most useful when a clear growth inhibition phenotype is observed with a minimal number of peptides and when protein-specific rescue is demonstrated.
The protein knockout method does not depend on prior knowledge of function and thus is well suited for use with genomics targets. Knowledge of function is often lacking for open reading frames (ORFs) discovered in genome sequencing, and even 20% of ORFs in the genome of the well-studied bacterium E. coli have no known function (43) . Another advantage of this method is the direct demonstration of essentiality on the protein level-the level at which an antimicrobial drug would act. Once essentiality of a protein is demonstrated, the method could also be used as a genetic tool to acquire functional information. For example, extragenic suppressors of peptide-induced death could be isolated. Function could also be addressed by the use of transcription profiling or proteomics approaches once it is known that the protein in question is essential.
Peptides shown to knock out function of a specific protein intracellularly can also be used as tools for drug screening (6) . For example, such a peptide could be competed from a target protein by small molecules suitable for drug development. In one instance, a peptide that specifically binds E. coli Dxr was used in a high-throughput "surrogate ligand" displacement assay: 32,000 compounds from a diverse historical library were screened in this way, and 30 compounds were identified that inhibited Dxr activity with 50% inhibitory concentrations under 20 M (20). This kind of peptide competition assay has been used to format other high-throughput screens for difficult-to-assay targets, such as DnaN, the sliding-clamp subunit of DNA polymerase III (D. J. Christensen, E. B. Gottlin, R. E. Benson, and P. T. Hamilton, Program Abstr. 41st Intersci. Conf. Antimicrob. Agents Chemother., abstr. 2131, 2001 .) The same format could also be used to discover drugs directed to targets of unknown function. For this purpose, the peptide and the target would both be validated for drug discovery by the results of peptide overexpression on cell growth.
